Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$106.42 /

-1.35 (-1.25%)

, AYLA

Ayala Pharmaceuticals

$12.00 /

-0.31 (-2.52%)

04:55
09/21/21
09/21
04:55
09/21/21
04:55

European Society for Medical Oncology to hold a virtual meeting

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ABBV

AbbVie

$106.42 /

-1.35 (-1.25%)

AYLA

Ayala Pharmaceuticals

$12.00 /

-0.31 (-2.52%)

DCPH

Deciphera

$32.28 /

-0.8 (-2.42%)

GMAB

Genmab

$42.88 /

-0.16 (-0.37%)

LPTX

Leap Therapeutics

$2.78 /

+0.125 (+4.72%)

ORIC

Oric Pharmaceuticals

$24.54 /

-0.67 (-2.66%)

SYNH

Syneos Health

$93.51 /

-0.83 (-0.88%)

BGNE

BeiGene

$398.49 /

-5.03 (-1.25%)

BMY

Bristol-Myers

$60.50 /

-0.82 (-1.34%)

BYSI

BeyondSpring

$15.37 /

-7.63 (-33.17%)

CALA

Calithera Biosciences

$2.18 /

-0.07 (-3.11%)

GILD

Gilead

$70.97 /

-0.64 (-0.89%)

GH

Guardant Health

$129.18 /

-2.57 (-1.95%)

LLY

Eli Lilly

$231.74 /

+1.57 (+0.68%)

IPSEY

Ipsen

$24.03 /

+0.105 (+0.44%)

EXAS

Exact Sciences

$105.28 /

-2.97 (-2.74%)

IDYA

Ideaya Biosciences

$26.22 /

-0.68 (-2.53%)

GSK

GlaxoSmithKline

$38.84 /

-0.1 (-0.26%)

RHHBY

Roche

$45.57 /

-0.5 (-1.09%)

REGN

Regeneron

$641.33 /

-10.43 (-1.60%)

PFE

Pfizer

$44.22 /

+0.325 (+0.74%)

TAK

Takeda Pharmaceutical

$17.07 /

-0.095 (-0.55%)

TMO

Thermo Fisher

$589.96 /

-6.64 (-1.11%)

TCRR

TCR2 Therapeutics

$9.39 /

-0.61 (-6.10%)

VERU

Veru

$8.45 /

-0.48 (-5.38%)

VBLT

VBL Therapeutics

$2.23 /

-0.085 (-3.67%)

VTRS

Viatris

$13.33 /

-0.24 (-1.77%)

NVS

Novartis

$82.81 /

-0.68 (-0.81%)

  • 21

    Sep

  • 24

    Sep

  • 27

    Sep

  • 28

    Sep

  • 30

    Sep

  • 07

    Oct

  • 07

    Oct

  • 10

    Oct

  • 18

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 27

    Oct

  • 08

    Nov

  • 30

    Nov

  • 01

    Dec

  • 29

    Dec

  • 28

    Jan

  • 06

    May

  • 07

    Oct

  • 13

    Nov

  • 19

    Nov

  • 02

    Dec

  • 02

    Dec

  • 20

    Jan

  • 18

    Feb

  • 01

    Mar

  • 09

    Apr

  • 04

    May

  • 03

    Jun

  • 08

    Jul

ABBV AbbVie
$106.42 /

-1.35 (-1.25%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
AYLA Ayala Pharmaceuticals
$12.00 /

-0.31 (-2.52%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$32.28 /

-0.8 (-2.42%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$42.88 /

-0.16 (-0.37%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.78 /

+0.125 (+4.72%)

09/19/21 Piper Sandler
Piper Sandler keeps Overweight on Leap Therapeutics, ups target to $5
09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$93.51 /

-0.83 (-0.88%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$398.49 /

-5.03 (-1.25%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$60.50 /

-0.82 (-1.34%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$15.37 /

-7.63 (-33.17%)

09/20/21 H.C. Wainwright
BeyondSpring price target lowered to $65 from $100 at H.C. Wainwright
09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
CALA Calithera Biosciences
$2.18 /

-0.07 (-3.11%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$70.97 /

-0.64 (-0.89%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$129.18 /

-2.57 (-1.95%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$231.74 /

+1.57 (+0.68%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$24.03 /

+0.105 (+0.44%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$105.28 /

-2.97 (-2.74%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.22 /

-0.68 (-2.53%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.84 /

-0.1 (-0.26%)

09/20/21 UBS
GlaxoSmithKline price target lowered to 1,460 GBp from 1,540 GBp at UBS
08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
RHHBY Roche
$45.57 /

-0.5 (-1.09%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
REGN Regeneron
$641.33 /

-10.43 (-1.60%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.07 /

-0.095 (-0.55%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
TMO Thermo Fisher
$589.96 /

-6.64 (-1.11%)

09/20/21 SVB Leerink
Thermo Fisher price target raised to $675 from $600 at SVB Leerink
09/20/21 JPMorgan
Thermo Fisher price target raised to $700 from $600 at JPMorgan
09/20/21 KeyBanc
Thermo Fisher price target raised to $710 from $555 at KeyBanc
09/20/21 Citi
Thermo Fisher price target raised to $620 from $535 at Citi
TCRR TCR2 Therapeutics
$9.39 /

-0.61 (-6.10%)

09/20/21 Truist
TCR2 Therapeutics price target lowered to $29 from $40 at Truist
09/20/21 H.C. Wainwright
TCR2 Therapeutics price target lowered to $25 from $37 at H.C. Wainwright
09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
VERU Veru
$8.45 /

-0.48 (-5.38%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.23 /

-0.085 (-3.67%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.33 /

-0.24 (-1.77%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$82.81 /

-0.68 (-0.81%)

09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
Largo Resources reports 3Q V205 production up 5% y-o-y to 3,260 tons » 06:15
10/20/21
10/20
06:15
10/20/21
06:15
LGO

Largo Resources

$11.55 /

+0.16 (+1.40%)

Largo Resources reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

08/16/21 RBC Capital
Largo Resources price target lowered to C$24 from C$25 at RBC Capital
06/30/21 RBC Capital
Largo Resources price target raised to C$25 from C$20 at RBC Capital
06/14/21 H.C. Wainwright
Largo Resources price target raised to $24 from $20 at H.C. Wainwright
04/19/21 Morgan Stanley
Largo Resources upgraded to Overweight from Equal Weight at Morgan Stanley
LGO Largo Resources
$11.55 /

+0.16 (+1.40%)

Downgrade
Western Union downgraded to Neutral from Buy at BTIG » 06:14
10/20/21
10/20
06:14
10/20/21
06:14
WU

Western Union

$20.17 /

-1.135 (-5.33%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WU Western Union
$20.17 /

-1.135 (-5.33%)

WU Western Union
$20.17 /

-1.135 (-5.33%)

10/14/21 Susquehanna
Western Union price target lowered to $23 from $26 at Susquehanna
09/27/21
Fly Intel: Top five analyst upgrades
09/27/21 Citi
Western Union upgraded to Buy from Neutral at Citi
07/16/21 Susquehanna
Western Union Digital undervalued by investors, says Susquehanna
WU Western Union
$20.17 /

-1.135 (-5.33%)

WU Western Union
$20.17 /

-1.135 (-5.33%)

WU Western Union
$20.17 /

-1.135 (-5.33%)

Initiation
Cyclerion Therapeutics initiated with a Buy at Truist » 06:13
10/20/21
10/20
06:13
10/20/21
06:13
CYCN

Cyclerion Therapeutics

/

+

Truist analyst Joon Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYCN Cyclerion Therapeutics
/

+

CYCN Cyclerion Therapeutics
/

+

09/24/21 Cantor Fitzgerald
Cyclerion Therapeutics initiated with an Overweight at Cantor Fitzgerald
CYCN Cyclerion Therapeutics
/

+

Downgrade
Ascendis Pharma downgraded to Neutral from Buy at BofA » 06:13
10/20/21
10/20
06:13
10/20/21
06:13
ASND

Ascendis Pharma

$153.36 /

-2.89 (-1.85%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

06:06 Today BofA
Ascendis Pharma downgraded to Neutral from Buy at BofA
08/26/21 Credit Suisse
Ascendis Pharma price target raised to $185 from $178 at Credit Suisse
08/26/21 JPMorgan
Ascendis Pharma price target raised to $175 from $172 at JPMorgan
07/27/21 Wedbush
Ascendis Pharma removed from Best Ideas List at Wedbush
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

  • 02
    Sep
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

Hot Stocks
Credit Suisse fined over GBP 147M by U.K.'s FCA » 06:13
10/20/21
10/20
06:13
10/20/21
06:13
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

The Financial Conduct…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Recommendations
Macy's spinning e-commerce unit does not make sense strategically, says Citi » 06:12
10/20/21
10/20
06:12
10/20/21
06:12
M

Macy's

$26.54 /

-1.705 (-6.04%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Gordon Haskett
Macy's upgraded to Buy from Hold at Gordon Haskett
09/09/21 Cowen
Cowen upgrades Macy's to Outperform, sees 'American icon reinvented'
09/09/21
Fly Intel: Top five analyst upgrades
M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

M Macy's
$26.54 /

-1.705 (-6.04%)

Hot Stocks
High Tide to transition cannabis retail stores to cannabis discount club concept » 06:12
10/20/21
10/20
06:12
10/20/21
06:12
HITI

High Tide

$5.99 /

+0.215 (+3.72%)

High Tide announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HITI High Tide
$5.99 /

+0.215 (+3.72%)

HITI High Tide
$5.99 /

+0.215 (+3.72%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.99 /

+0.215 (+3.72%)

HITI High Tide
$5.99 /

+0.215 (+3.72%)

Downgrade
Netflix downgraded to Hold from Buy at Deutsche Bank » 06:11
10/20/21
10/20
06:11
10/20/21
06:11
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

04:58 Today Piper Sandler
Netflix Q4 content slate 'still looks compelling,' says Piper Sandler
04:51 Today Pivotal Research
Netflix price target raised to $750 from $700 at Pivotal Research
10/19/21 Truist
Netflix's Q3 results 'very solid', says Truist
10/18/21 Loop Capital
Netflix price target raised to $700 from $650 at Loop Capital
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Hot Stocks
Credit Suisse to pay nearly $100M to SEC to resolve Mozambique charges » 06:11
10/20/21
10/20
06:11
10/20/21
06:11
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

Credit Suisse Group AG…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Hot Stocks
Matador provides operational update » 06:11
10/20/21
10/20
06:11
10/20/21
06:11
MTDR

Matador

$43.00 /

-0.84 (-1.92%)

Matador provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTDR Matador
$43.00 /

-0.84 (-1.92%)

MTDR Matador
$43.00 /

-0.84 (-1.92%)

10/13/21 Wells Fargo
Matador price target raised to $46 from $40 at Wells Fargo
10/07/21 Truist
Matador price target raised to $54 from $50 at Truist
09/15/21
Fly Intel: Top five analyst upgrades
09/15/21 JPMorgan
Matador upgraded to Overweight from Neutral at JPMorgan
MTDR Matador
$43.00 /

-0.84 (-1.92%)

MTDR Matador
$43.00 /

-0.84 (-1.92%)

Hot Stocks
Trade Desk announces advertising partnership with Xiaomi » 06:09
10/20/21
10/20
06:09
10/20/21
06:09
TTD

Trade Desk

$81.39 /

+0.545 (+0.67%)

, XIACF

Xiaomi

$2.93 /

+0.18 (+6.55%)

The Trade Desk (TTD)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

XIACF Xiaomi
$2.93 /

+0.18 (+6.55%)

TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

10/04/21 Vertical Group
Trade Desk downgraded to Neutral from Buy at Vertical Group
09/30/21 Cleveland Research
Trade Desk initiated with a Buy at Cleveland Research
09/22/21 Berenberg
Trade Desk assumed with a Buy at Berenberg
08/17/21 Citi
Trade Desk price target raised to $85 from $60 at Citi
XIACF Xiaomi
$2.93 /

+0.18 (+6.55%)

03/16/21 Citi
Xiaomi upgraded to Buy from Sell at Citi
03/16/21 HSBC
Xiaomi upgraded to Buy from Hold at HSBC
11/25/20 Macquarie
Xiaomi downgraded to Underperform from Neutral at Macquarie
11/25/20 Daiwa
Xiaomi downgraded to Hold from Buy at Daiwa
TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

XIACF Xiaomi
$2.93 /

+0.18 (+6.55%)

TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

TTD Trade Desk
$81.39 /

+0.545 (+0.67%)

Hot Stocks
Credit Suisse resolves fraudulent Mozambique loan case in global resolution » 06:09
10/20/21
10/20
06:09
10/20/21
06:09
CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

Credit Suisse, a global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

Initiation
Compass Therapeutics initiated with a Buy at H.C. Wainwright » 06:07
10/20/21
10/20
06:07
10/20/21
06:07
CMPX

Compass Therapeutics

$3.25 /

+0.05 (+1.56%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPX Compass Therapeutics
$3.25 /

+0.05 (+1.56%)

10/01/21 Benchmark
Compass Therapeutics initiated with a Speculative Buy at Benchmark
  • 13
    Nov
Hot Stocks
Enviva, GreenGasUSA announce 10-year renewable natural gas agreement » 06:07
10/20/21
10/20
06:07
10/20/21
06:07
EVA

Enviva

$65.69 /

+0.2 (+0.31%)

Enviva Partners and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVA Enviva
$65.69 /

+0.2 (+0.31%)

EVA Enviva
$65.69 /

+0.2 (+0.31%)

10/18/21 RBC Capital
Enviva price target raised to $75 from $60 at RBC Capital
10/18/21 Barclays
Enviva price target raised to $80 from $67 at Barclays
10/05/21 Raymond James
Enviva downgraded to Outperform from Strong Buy at Raymond James
09/07/21 JPMorgan
Enviva initiated with Overweight, $63 price target at JPMorgan
EVA Enviva
$65.69 /

+0.2 (+0.31%)

  • 04
    Jun
Periodicals
Facebook plans to change name to reflect metaverse focus, The Verge reports » 06:07
10/20/21
10/20
06:07
10/20/21
06:07
FB

Facebook

$340.06 /

+4.62 (+1.38%)

Facebook is planning to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

Downgrade
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright » 06:06
10/20/21
10/20
06:06
10/20/21
06:06
GRTX

Galera Therapeutics

/

+

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTX Galera Therapeutics
/

+

GRTX Galera Therapeutics
/

+

10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
10/19/21 BTIG
Galera Therapeutics downgraded to Neutral from Buy at BTIG
10/19/21 Roth Capital
Roth Capital bullish on Monopar Therapeutics after competitor trial fails
GRTX Galera Therapeutics
/

+

GRTX Galera Therapeutics
/

+

GRTX Galera Therapeutics
/

+

Downgrade
Ascendis Pharma downgraded to Neutral from Buy at BofA » 06:06
10/20/21
10/20
06:06
10/20/21
06:06
ASND

Ascendis Pharma

$153.36 /

-2.89 (-1.85%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

08/26/21 Credit Suisse
Ascendis Pharma price target raised to $185 from $178 at Credit Suisse
08/26/21 JPMorgan
Ascendis Pharma price target raised to $175 from $172 at JPMorgan
07/27/21 Wedbush
Ascendis Pharma removed from Best Ideas List at Wedbush
07/08/21 Canaccord
Ascendis Pharma recent selloff a buying opportunity, says Canaccord
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

  • 02
    Sep
ASND Ascendis Pharma
$153.36 /

-2.89 (-1.85%)

Hot Stocks
Micron announces over $150B in manufacturing and R&D investments » 06:06
10/20/21
10/20
06:06
10/20/21
06:06
MU

Micron

$67.58 /

+0.31 (+0.46%)

Micron Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

06:05 Today Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

Downgrade
Micron downgraded to Neutral from Buy at Mizuho » 06:05
10/20/21
10/20
06:05
10/20/21
06:05
MU

Micron

$67.58 /

+0.31 (+0.46%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

MU Micron
$67.58 /

+0.31 (+0.46%)

Downgrade
Apollo Global downgraded to Perform from Outperform at Oppenheimer » 06:05
10/20/21
10/20
06:05
10/20/21
06:05
APO

Apollo Global

/

+

Oppenheimer analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APO Apollo Global
/

+

APO Apollo Global
/

+

10/14/21 BMO Capital
JPMorgan price target raised to $140 from $139 at BMO Capital
09/16/21 Morgan Stanley
Reported offer to keep floor under Tronox's share price, says Morgan Stanley
08/05/21 Oppenheimer
Apollo Global price target raised to $67 from $62 at Oppenheimer
08/03/21 Morgan Stanley
Apollo Global, Nasdaq named Diversified Financials Top Picks at Morgan Stanley
APO Apollo Global
/

+

APO Apollo Global
/

+

APO Apollo Global
/

+

APO Apollo Global
/

+

Recommendations
PacWest Bancorp price target raised to $62 from $56 at Piper Sandler » 06:05
10/20/21
10/20
06:05
10/20/21
06:05
PACW

PacWest Bancorp

$47.82 /

-0.305 (-0.63%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PACW PacWest Bancorp
$47.82 /

-0.305 (-0.63%)

PACW PacWest Bancorp
$47.82 /

-0.305 (-0.63%)

10/19/21 Raymond James
PacWest Bancorp price target raised to $57 from $55 at Raymond James
10/07/21 Wells Fargo
PacWest Bancorp price target raised to $60 from $50 at Wells Fargo
09/21/21 Truist
Truist upgrades PacWest Bancorp to Buy on excess liquidity, growth potential
09/21/21 Truist
PacWest Bancorp upgraded to Buy from Hold at Truist
PACW PacWest Bancorp
$47.82 /

-0.305 (-0.63%)

PACW PacWest Bancorp
$47.82 /

-0.305 (-0.63%)

Earnings
FirstCash reports Q3 adjusted EPS 84c, consensus 81c » 06:05
10/20/21
10/20
06:05
10/20/21
06:05
FCFS

FirstCash

$89.19 /

+1.67 (+1.91%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FCFS FirstCash
$89.19 /

+1.67 (+1.91%)

FCFS FirstCash
$89.19 /

+1.67 (+1.91%)

09/08/21 Wedbush
FirstCash price target raised to $90 from $82 at Wedbush
08/17/21 Barclays
FirstCash price target raised to $95 from $86 at Barclays
06/22/21 Credit Suisse
FirstCash downgraded to Underperform from Outperform at Credit Suisse
05/24/21 Janney Montgomery Scott
FirstCash downgraded to Neutral from Buy at Janney Montgomery Scott
FCFS FirstCash
$89.19 /

+1.67 (+1.91%)

Hot Stocks
Anthem: Medical enrollment totaled 45.1M members at September 30 » 06:04
10/20/21
10/20
06:04
10/20/21
06:04
ANTM

Anthem

$393.55 /

+5.39 (+1.39%)

Medical enrollment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANTM Anthem
$393.55 /

+5.39 (+1.39%)

ANTM Anthem
$393.55 /

+5.39 (+1.39%)

09/27/21 SVB Leerink
Anthem initiated with a Market Perform at SVB Leerink
09/27/21 SVB Leerink
Anthem initiated with a Market Perform at SVB Leerink
09/09/21 Cowen
Anthem can gain profitable market share, says Cowen
09/09/21 Cowen
Anthem initiated with an Outperform at Cowen
ANTM Anthem
$393.55 /

+5.39 (+1.39%)

ANTM Anthem
$393.55 /

+5.39 (+1.39%)

ANTM Anthem
$393.55 /

+5.39 (+1.39%)

ANTM Anthem
$393.55 /

+5.39 (+1.39%)

Downgrade
BHP Group downgraded to Hold from Buy at Jefferies » 06:04
10/20/21
10/20
06:04
10/20/21
06:04
BBL

BHP Group

$55.84 /

+0.275 (+0.49%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBL BHP Group
$55.84 /

+0.275 (+0.49%)

09/28/21 RBC Capital
BHP Group downgraded on concentrated China exposure at RBC Capital
09/28/21 RBC Capital
BHP Group downgraded to Sector Perform from Outperform at RBC Capital
09/17/21 UBS
BHP Group price target lowered to 1,900 GBp from 2,000 GBp at UBS
09/16/21 Deutsche Bank
BHP Group price target lowered to 2,200 GBp from 2,400 GBp at Deutsche Bank
BBL BHP Group
$55.84 /

+0.275 (+0.49%)

Downgrade
Rio Tinto downgraded to Hold from Buy at Jefferies » 06:04
10/20/21
10/20
06:04
10/20/21
06:04
RIO

Rio Tinto

$70.89 /

+0.68 (+0.97%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIO Rio Tinto
$70.89 /

+0.68 (+0.97%)

RIO Rio Tinto
$70.89 /

+0.68 (+0.97%)

10/18/21 UBS
Rio Tinto price target lowered to 4,100 GBp from 4,200 GBp at UBS
10/11/21 JPMorgan
Rio Tinto price target lowered to 6,800 GBp from 7,210 GBp at JPMorgan
10/06/21 Exane BNP Paribas
Rio Tinto upgraded to Outperform at Exane BNP Paribas on valuation
10/06/21 Exane BNP Paribas
Rio Tinto upgraded to Outperform from Neutral at Exane BNP Paribas
RIO Rio Tinto
$70.89 /

+0.68 (+0.97%)

RIO Rio Tinto
$70.89 /

+0.68 (+0.97%)

RIO Rio Tinto
$70.89 /

+0.68 (+0.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.